 |
OxThera
Last updated: August 10, 2024
Founder Martijn Kleijwegt
Sweden | Funding: $87.6M (+)
Website: http://www.oxthera.com/
OxThera is developing its Oxabact therapy that uses the O. formigenes bacteria to degrade oxalates in the intestines.
Website: http://www.oxthera.com/
OxThera is developing its Oxabact therapy that uses the O. formigenes bacteria to degrade oxalates in the intestines.
